Acadia Pharmaceutica (ACAD)
14.66 -0.07 (-0.48%) 04/28/25 [NASDAQ]
14.40 x 100 16.00 x 100
Realtime by (Cboe BZX)
14.40 x 100 16.00 x 100
Realtime 14.40 -0.26 (-1.77%) 04:10 ET
for Mon, Apr 28th, 2025
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
Cash Flows From Operating Activities | |||||
Net Income | 226,451 | -61,286 | -215,975 | -167,870 | -281,584 |
Depreciation Amortization | 6,579 | -1,981 | -710 | 5,748 | 4,402 |
Accounts receivable | -472 | -36,072 | 2,171 | -16,119 | -12,466 |
Accounts payable and accrued liabilities | -1,351 | 4,797 | 5,870 | -1,617 | 1,271 |
Other Working Capital | 4,155 | 18,133 | 37,991 | -24,824 | 11,036 |
Other Operating Activity | -77,643 | 93,111 | 56,618 | 79,022 | 141,175 |
Operating Cash Flow | $157,719 | $16,702 | $-114,035 | $-125,660 | $-136,166 |
Cash Flows From Investing Activities | |||||
Change In Deposits | -176,530 | 59,795 | 73,241 | -69,980 | 200,096 |
PPE Investments | -523 | -50 | N/A | -1,122 | -7,587 |
Sale Of Investment | N/A | 12,253 | N/A | N/A | N/A |
Purchase Sale Intangibles | N/A | -40,000 | N/A | N/A | N/A |
Other Investing Activity | 146,515 | -40,000 | 0 | 0 | 0 |
Investing Cash Flow | $-30,538 | $31,998 | $73,241 | $-71,102 | $192,509 |
Cash Flows From Financing Activities | |||||
Common Stock Issued | 6,845 | 25,129 | 8,199 | 18,162 | 80,996 |
Financing Cash Flow | $6,845 | $25,129 | $8,199 | $18,162 | $80,996 |
Exchange Rate Effect | -94 | -18 | 6 | 7 | -8 |
Beginning Cash Position | 194,427 | 120,616 | 153,205 | 331,798 | 194,467 |
End Cash Position | 328,359 | 194,427 | 120,616 | 153,205 | 331,798 |
Net Cash Flow | $133,932 | $73,811 | $-32,589 | $-178,593 | $137,331 |
Free Cash Flow | |||||
Operating Cash Flow | 157,719 | 16,702 | -114,035 | -125,660 | -136,166 |
Capital Expenditure | -523 | -50 | N/A | -1,122 | -7,587 |
Free Cash Flow | 157,196 | 16,652 | -114,035 | -126,782 | -143,753 |